Attached files
| file | filename |
|---|---|
| EX-10.27.4 - EX-10.27.4 - ALBIREO PHARMA, INC. | albo-ex10274_603.htm |
| EX-32.1 - EX-32.1 - ALBIREO PHARMA, INC. | albo-ex321_10.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-ex312_11.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-ex311_7.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | albo-ex211_280.htm |
| EX-10.28 - EX-10.28 - ALBIREO PHARMA, INC. | albo-ex1028_403.htm |
| EX-10.25 - EX-10.25 - ALBIREO PHARMA, INC. | albo-ex1025_282.htm |
| EX-10.11 - EX-10.11 - ALBIREO PHARMA, INC. | albo-ex1011_281.htm |
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-10k_20171231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
|
(1) |
Registration Statement (Form S-8 No. 333-144407) pertaining to the 2005 Employee Stock Purchase Plan, 2004 Stock Incentive Plan and 2005 Non-Employee Directors’ Stock Option Plan; |
|
|
(2) |
Registration Statement (Form S-8 No. 333-168903) pertaining to the Amended and Restated 2010 Stock Incentive Plan; |
|
|
(3) |
Registration Statement (Form S-8 No. 333-180409) pertaining to the Amended and Restated 2010 Stock Incentive Plan; |
|
|
(4) |
Registration Statement (Form S-8 No. 333-215264) pertaining to the 2016 Equity Incentive Plan and the Amended and Restated 2010 Stock Incentive Plan; |
|
|
(5) |
Registration Statement (Form S-8 No. 333-222131) pertaining to the 2017 Inducement Equity Incentive Plan; and |
|
|
(6) |
Registration Statement (Form S-3 No. 333-220958) of Albireo Pharma, Inc.; |
of our reports dated March 27, 2018, with respect to the consolidated financial statements of Albireo Pharma, Inc. and the effectiveness of internal control over financial reporting of Albireo Pharma, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 27, 2018